BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 27, 2005
View Archived Issues
Allopregnanolone shows efficacy in a rat model of spontaneous recurrent seizures
Read More
Analogues of etodolac from Salmedix for MM
Read More
A3R agonism effective for cholangiocarcinoma
Read More
Trend toward positive survival benefit in patients treated with Zadaxin plus TACE
Read More
BioCryst cleared to study intravenous peramivir in phase I
Read More
Updated antibacterial efficacy of tebipenem pivoxil presented at ICAAC
Read More
New phase I/II trial of intravenous Fodosine in B-cell ALL
Read More
SPA agreement for phase III study of ramoplanin
Read More
Sirna selects Sirna-AV34 as development candidate for hepatitis C
Read More
Exelixis and Wyeth sign licensing agreement for compounds targeting FXR
Read More
Japanese approval for expanded use of Peg-Intron and Rebetol in HCV
Read More
Genzyme acquires gene therapy assets from Avigen
Read More
FTC clearance for Roche's licensing of BCX-4208
Read More
AtheroGenics and AstraZeneca sign agreement for AGI-1067
Read More
Bristol-Myers Squibb and Merck & Co. terminate muraglitazar agreement
Read More
Sinovac begins clinical testing of Panflu H5N1 vaccine
Read More
Enrollment update for AI-700 phase III program
Read More
Approval letter for Biovail's ODT formulation of citalopram hydrobromide
Read More
Orphan drug designation for eniluracil in liver cancer
Read More
Wyeth submits NDA for desvenlafaxine extended release
Read More
CT-32228 shows promise for treatment of imatinib-resistant CML
Read More
Phase II Cloretazine data presented
Read More
Quinoline and benzimidazole derivatives as potential candidates for presymptomatic diagnosis of AD
Read More
New D3 receptor antagonist exhibits antipsychotic properties in models of schizophrenia
Read More
Recent patents report novel analgesic agents
Read More
New therapeutic agents for skin disorders disclosed in recent Galderma patent
Read More
Recent patents report new therapeutic agents for diabetes and other endocrine-related disorders
Read More